Vectorite Biomedical Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 12.441 million compared to TWD 10.669 million a year ago. Operating loss was TWD 24.382 million compared to TWD 33.437 million a year ago. Net income was TWD 20.018 million compared to net loss of TWD 31.475 million a year ago. Basic earnings per share was TWD 0.29 compared to basic loss per share of TWD 0.75 a year ago.